913375-88-9

Usage

Molecular structure

1-methyl-2-phenyl-5-(pyridin-4-yl)-1,2-dihydropyrazol-3-one has a complex molecular structure, featuring a dihydropyrazolone core, a methyl group, a phenyl group, and a pyridin-4-yl group.

Classification

It is a dihydropyrazolone derivative, which is a type of organic compound.

Functional groups

The compound contains a methyl group (-CH3), a phenyl group (a ring of six carbon atoms with delocalized electrons), and a pyridin-4-yl group (a nitrogen-containing ring structure).

Biological activities

1-methyl-2-phenyl-5-(pyridin-4-yl)-1,2-dihydropyrazol-3-one may exhibit biological activities, making it a potential candidate for further study in the context of medicinal properties.

Research potential

The compound's precise chemical structure and potential uses make it an interesting subject for further research and investigation in both chemistry and pharmaceutical fields.

Upstream product

• 26377-17-3 ethyl 3-oxo-3-(4-pyridyl)propanoate 
• 622-36-6 1-methyl-2-phenylhydrazine 
• 829-45-8 methyl 3-(pyridin-4-yl)-3-oxo-propionate 

Downstream Products

• 913375-89-0 1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carbaldehyde 
• 913375-90-3 1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxylic acid 

Relevant academic research and scientific papers

Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series

As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2- phenyl-2,3-dihydro-1H-pyrazole-4-c

SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.